Drugs / Kalinox
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT00643838 | Dec 2007 → Jul 2008 | smooth surface dental caries | Air Liquide | Completed | No outcome recorded |
| Phase 43 trials · 2 met primary | ||||||
| Phase 4 | NCT01356745 | Feb 2010 → May 2011 | — | University Hospital, Toulouse | Completed | Met primary |
| Phase 4 | NCT00643656 | Oct 2007 → Jun 2008 | — | Air Liquide | Completed | Met primary |
| Phase 4 | NCT00646945 | Sep 2007 → Oct 2008 | cancer | Air Liquide | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03755895 Background | Nov 2019 → May 2022 | cancer | Institut de Cancérologie de Lorraine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kalinox | “A clinical trial of efficacy and safety of inhalation sedation with a 50% nitrous oxide/oxygen premix (Kalinox™) in general practice.” PMID 22186944 ↗ Mar 2011 |
| Known as | Premixed 50% nitrous oxide and oxygen | “Premixed 50% nitrous oxide and oxygen (Kalinox)” NCT01356745 ↗ |
| Route | Inhaled | “inhalation sedation with a 50% nitrous oxide/oxygen premix (Kalinox™)” PMID 22186944 ↗ Mar 2011 |